Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Austria
Countries of investment
  • USA
Investment stages
  • Seed
  • Series A
Industries
  • Fintech
  • Web3
About
Ribbon Biolabs revolutionizes DNA synthesis with cutting-edge technology, empowering biotech industry and academia to innovate and tackle challenges in synthetic biology.
Min check size
$50K
Max check size
$1M
Fund size
NPS

Investment Thesis

Ribbon Biolabs focuses on developing revolutionary technology for the fast and efficient automated synthesis of DNA, making complex DNA accessible and affordable for customers in the biotech industry and academia.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With a robust background in venture capital, the fund manager has actively participated in over 50 investments across the biotechnology and healthcare sectors. This individual specializes in early-stage opportunities, emphasizing a data-driven approach to identify transformative innovations. Their strategic style is characterized by a thematic focus on disruptive technologies, particularly within North America and Europe. Notable exits include several high-profile acquisitions, underscoring their adeptness at navigating complex market landscapes.

Ribbon Biolabs Contacts Information

Primary contact

Team

Lukas Leiendecker

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp